Regeneron Pharmaceuticals, Inc.
Pharma company reports second quarter financial and operating results
Published in Lab Business Week, September 4th, 2005
Regeneron reported a net loss of $27.0 million, or $0.48 per share (basic and diluted), for the second quarter of 2005 and a net loss of $31.1 million, or $0.56 per share (basic and diluted), for the 6 months ended June 30, 2005.
Excluding the effects of expensing stock options in 2005, Regeneron had a net loss of $21.7 million, or $0.38 per share (basic and diluted), in the second quarter and a net loss of $20.4 million, or $0.37 per share (basic and diluted), for the first 6 months compared with a net loss of $14.5 million, or $0.26 per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-09-04)
More Articles from Lab Business Week
- AEterna Zentaris, Inc.
Biopharmaceutical firm reports earnings of $0.36 per share - ATS Medical, Inc.
Medical device firm reports 23.3% increase in sales - Abaxis, Inc.
Medical device firm reports 11th consecutive profitable quarter - Abiomed, Inc.
Medical device firm reports 13% increase in revenues, clinical update - Able Laboratories, Inc.
Generic pharmaceutical maker receives notice of delisting from Nasdaq - Adams Respiratory Therapeutics, Inc.
Pharmaceutical company closes initial public offering - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
